Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality, China
Contact: Study coordinator (Qiao Li, MD) · liqiaopumc@qq.com · 86-87788820

Study leads

Qiao Li, MD
Study Director
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

Female Breast Cancer · Prostate Cancer · Colorectal Carcinoma

Abroad (travel likely)Recruiting

Detroit, United States

A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug as a Radiosensitizer in Patients With Advanced Breast Cancer Brain Metastasis.

Advanced Breast Cancer Brain Metastasis

Abroad (travel likely)Recruiting

Beijing, China

VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients

Breast Cancer

Abroad (travel likely)Recruiting

Chapel Hill, United States

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Breast Cancer · Quality of Life

Abroad (travel likely)RecruitingPHASE2

Chapel Hill, United States